Trespassing cancer cells: 'fingerprinting' invasive protrusions reveals metastatic culprits

Current Opinion in Cell Biology

Volumn 24, Issue 5, 2012, Pages 662-669

  Klemke, Richard L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 6; ALPHA ACTININ; BETA ARRESTIN; BETA1 INTEGRIN; BETA3 INTEGRIN; CALDESMON; CALPAIN; CAVEOLIN 1; CORTACTIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOPLASM PROTEIN; DYNAMIN II; FASCIN; FOCAL ADHESION KINASE 2; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; HERMES ANTIGEN; INITIATION FACTOR 4E; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEURAL WISKOTT ALDRICH SYNDROME PROTEIN; PAXILLIN; PROTEIN CDC42; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; RAC1 PROTEIN; RAC2 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SEPTIN; TALIN;

CANCER CELL; CELL ADHESION; CELL CONTACT; CYTOPLASM; GENOMICS; HUMAN; INVADOPODIA; METASTASIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; PSEUDOPODIUM; REVIEW;

ANIMALS; CELL MOVEMENT; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASM INVASIVENESS; NEOPLASMS; PROTEOMICS; PSEUDOPODIA; RNA, NEOPLASM;

EID: 84867893769     PISSN: 09550674     EISSN: 18790410     Source Type: Journal    
DOI: 10.1016/j.ceb.2012.08.005     Document Type: Review

References (60)

1. Valastyan S., Weinberg R.A. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011, 147:275-292.
2. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
3. Mina L.A., Sledge G.W. Rethinking the metastatic cascade as a therapeutic target. Nat Rev Clin Oncol 2011, 8:325-332.
4. Courtneidge S.A. Cell migration and invasion in human disease: the tks adaptor proteins. Biochem Soc Trans 2012, 40:129-132.
5. Seals D.F., Azucena E.F., Pass I., Tesfay L., Gordon R., Woodrow M., Resau J.H., Courtneidge S.A. The adaptor protein tks5/fish is required for podosome formation and function, and for the protease-driven invasion of cancer cells. Cancer Cell 2005, 7:155-165.
6. Saltel F., Daubon T., Juin A., Ganuza I.E., Veillat V., Genot E. Invadosomes: intriguing structures with promise. Eur J Cell Biol 2011, 90:100-107.
7. Carman C.V. Mechanisms for transcellular diapedesis: probing and pathfinding by 'invadosome-like protrusions'. J Cell Sci 2009, 122(Pt 17):3025-3035.
8. Destaing O., Block M.R., Planus E., Albiges-Rizo C. Invadosome regulation by adhesion signaling. Curr Opin Cell Biol 2011, 23:597-606.
9. Linder S., Wiesner C., Himmel M. Degrading devices: invadosomes in proteolytic cell invasion. Annu Rev Cell Dev Biol 2011, 27:185-211.
10. Linder S. Invadosomes at a glance. J Cell Sci 2009, 122(Pt 17):3009-3013.
11. Ridley A.J. Life at the leading edge. Cell 2011, 145:1012-1022.
12. Nurnberg A., Kitzing T., Grosse R. Nucleating actin for invasion. Nat Rev Cancer 2011, 11:177-187.
13. Shibue T., Weinberg R.A. Metastatic colonization: settlement, adaptation and propagation of tumor cells in a foreign tissue environment. Semin Cancer Biol 2011, 21:99-106.
14. Hunter K. Host genetics influence tumour metastasis. Nat Rev Cancer 2006, 6:141-146.
15. Condeelis J.S., Wyckoff J.B., Bailly M., Pestell R., Lawrence D., Backer J., Segall J.E. Lamellipodia in invasion. Semin Cancer Biol 2001, 11:119-128.
16. Wang W., Goswami S., Sahai E., Wyckoff J.B., Segall J.E., Condeelis J.S. Tumor cells caught in the act of invading: their strategy for enhanced cell motility. Trends Cell Biol 2005, 15:138-145.
17. Stoletov K., Kato H., Zardouzian E., Kelber J., Yang J., Shattil S., Klemke R. Visualizing extravasation dynamics of metastatic tumor cells. J Cell Sci 2010, 123(Pt 13):2332-2341.
18. Stoletov K., Montel V., Lester R.D., Gonias S.L., Klemke R. High-resolution imaging of the dynamic tumor cell vascular interface in transparent zebrafish. Proc Natl Acad Sci USA 2007, 104:17406-17411.
19. Murphy D.A., Courtneidge S.A. The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function. Nat Rev Mol Cell Biol 2011, 12:413-426.
20. Attanasio F., Caldieri G., Giacchetti G., van Horssen R., Wieringa B., Buccione R. Novel invadopodia components revealed by differential proteomic analysis. Eur J Cell Biol 2011, 90:115-127.
21. Blouw B., Seals D.F., Pass I., Diaz B., Courtneidge S.A. A role for the podosome/invadopodia scaffold protein tks5 in tumor growth in vivo. Eur J Cell Biol 2008, 87:555-567.
22. Courtneidge S.A., Azucena E.F., Pass I., Seals D.F., Tesfay L. The src substrate tks5, podosomes (invadopodia), and cancer cell invasion. Cold Spring Harb Symp Quant Biol 2005, 70:167-171.
23. Li X., Zheng H., Hara T., Takahashi H., Masuda S., Wang Z., Yang X., Guan Y., Takano Y. Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas. Int J Oncol 2008, 33:69-79.
24. Chen J.Y., Tang Y.A., Huang S.M., Juan H.F., Wu L.W., Sun Y.C., Wang S.C., Wu K.W., Balraj G., Chang T.T., Li W.S., et al. A novel sialyltransferase inhibitor suppresses fak/paxillin signaling and cancer angiogenesis and metastasis pathways. Cancer Res 2011, 71:473-483.
25. Montero J.C., Seoane S., Ocana A., Pandiella A. Inhibition of src family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors. Clin Cancer Res 2011, 17:5546-5552.
26. Chahrour O., Cairns D., Omran Z. Small molecule kinase inhibitors as anti-cancer therapeutics. Mini Rev Med Chem 2012, 12:399-411.
27. Bourboulia D., Stetler-Stevenson W.G. Matrix metalloproteinases (mmps) and tissue inhibitors of metalloproteinases (timps): positive and negative regulators in tumor cell adhesion. Semin Cancer Biol 2010, 20:161-168.
28. Maudsley S., Chadwick W., Wang L., Zhou Y., Martin B., Park S.S. Bioinformatic approaches to metabolic pathways analysis. Methods Mol Biol 2011, 756:99-130.
29. Kim Y.A., Wuchty S., Przytycka T.M. Identifying causal genes and dysregulated pathways in complex diseases. PLoS Comput Biol 2011, 7:e1001095.
30. Wang Y., Ding S.J., Wang W., Jacobs J.M., Qian W.J., Moore R.J., Yang F., Camp D.G., Smith R.D., Klemke R.L. Profiling signaling polarity in chemotactic cells. Proc Natl Acad Sci USA 2007, 104:8328-8333.
31. Wang Y., Klemke R.L. Proteomics method for identification of pseudopodium phosphotyrosine proteins. Methods Mol Biol 2012, 757:349-365.
32. Jia Z., Barbier L., Stuart H., Amraei M., Pelech S., Dennis J.W., Metalnikov P., O'Donnell P., Nabi I.R. Tumor cell pseudopodial protrusions. Localized signaling domains coordinating cytoskeleton remodeling, cell adhesion, glycolysis, rna translocation, and protein translation. J Biol Chem 2005, 280:30564-30573.
33. Shankar J., Messenberg A., Chan J., Underhill T.M., Foster L.J., Nabi I.R. Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells. Cancer Res 2010, 70:3780-3790.
34. Shankar J., Nabi I.R. Rna purification from tumor cell protrusions using porous polycarbonate filters. Methods Mol Biol 2011, 714:353-366.
35. Cho S.Y., Klemke R.L. Purification of pseudopodia from polarized cells reveals redistribution and activation of rac through assembly of a cas/crk scaffold. J Cell Biol 2002, 156:725-736.
36. Jia Z., Vadnais J., Lu M.L., Noel J., Nabi I.R. Rho/rock-dependent pseudopodial protrusion and cellular blebbing are regulated by p38 mapk in tumour cells exhibiting autocrine c-met activation. Biol Cell 2006, 98:337-351.
37. Wang Y., Klemke R.L. Biochemical purification of pseudopodia from migratory cells. Methods Mol Biol 2007, 370:55-66.
38. Kelber J.A., Klemke R.L. Peak1, a novel kinase target in the fight against cancer. Oncotarget 2010, 1:219-223.
39. Wang Y., Kelber J.A., Tran Cao H.S., Cantin G.T., Lin R., Wang W., Kaushal S., Bristow J.M., Edgington T.S., Hoffman R.M., et al. Pseudopodium-enriched atypical kinase 1 regulates the cytoskeleton and cancer progression [corrected]. Proc Natl Acad Sci USA 2010, 107:10920-10925.
40. Kelber J.A., Reno T., Kaushal S., Metildi C., Wright T., Stoletov K., Weems J., Park F.D., Mose E., Wang Y., Hoffman R.M., Lowy A.M., Bouvet M., Klemke R.L. KRas induces a Src/PEAK1/ErbB2 kinase amplification loop that drives metastatic growth and therapy resistance in pancreatic cancer. Cancer Research 2012, 72:2554-2564.
41. Yang J., Weinberg R.A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 2008, 14:818-829.
42. Montagna C., Lyu M.S., Hunter K., Lukes L., Lowther W., Reppert T., Hissong B., Weaver Z., Ried T. The septin 9 (msf) gene is amplified and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines. Cancer Res 2003, 63:2179-2187.
43. McKiernan E., McDermott E.W., Evoy D., Crown J., Duffy M.J. The role of s100 genes in breast cancer progression. Tumour Biol 2011, 32:441-450.
44. He H., Li J., Weng S., Li M., Yu Y. S100a11: diverse function and pathology corresponding to different target proteins. Cell Biochem Biophys 2009, 55:117-126.
45. Blagden S.P., Willis A.E. The biological and therapeutic relevance of mrna translation in cancer. Nat Rev Clin Oncol 2011, 8:280-291.
46. Hsieh A.C., Liu Y., Edlind M.P., Ingolia N.T., Janes M.R., Sher A., Shi E.Y., Stumpf C.R., Christensen C., Bonham M.J., et al. The translational landscape of mtor signalling steers cancer initiation and metastasis. Nature 2012, 485:55-61.
47. Stuart H.C., Jia Z., Messenberg A., Joshi B., Underhill T.M., Moukhles H., Nabi I.R. Localized rho gtpase activation regulates rna dynamics and compartmentalization in tumor cell protrusions. J Biol Chem 2008, 283:34785-34795.
48. Mili S., Moissoglu K., Macara I.G. Genome-wide screen reveals apc-associated rnas enriched in cell protrusions. Nature 2008, 453:115-119.
49. Willett M., Brocard M., Davide A., Morley S.J. Translation initiation factors and active sites of protein synthesis co-localize at the leading edge of migrating fibroblasts. Biochem J 2011, 438:217-227.
50. Willett M., Flint S.A., Morley S.J., Pain V.M. Compartmentalisation and localisation of the translation initiation factor (eif) 4f complex in normally growing fibroblasts. Exp Cell Res 2006, 312:2942-2953.
51. Schiller H.B., Friedel C.C., Boulegue C., Fassler R. Quantitative proteomics of the integrin adhesome show a myosin II-dependent recruitment of lim domain proteins. EMBO Rep 2011, 12:259-266.
52. Silvera D., Formenti S.C., Schneider R.J. Translational control in cancer. Nat Rev Cancer 2010, 10:254-266.
53. Clement P.M., Johansson H.E., Wolff E.C., Park M.H. Differential expression of eif5a-1 and eif5a-2 in human cancer cells. FEBS J 2006, 273:1102-1114.
54. He L.R., Zhao H.Y., Li B.K., Liu Y.H., Liu M.Z., Guan X.Y., Bian X.W., Zeng Y.X., Xie D. Overexpression of eif5a-2 is an adverse prognostic marker of survival in stage i non-small cell lung cancer patients. Int J Cancer 2011, 129:143-150.
55. Quintavalle M., Elia L., Price J.H., Heynen-Genel S., Courtneidge S.A. A cell-based high-content screening assay reveals activators and inhibitors of cancer cell invasion. Sci Signal 2011, 4:ra49.
56. Howe A.K., Baldor L.C., Hogan B.P. Spatial regulation of the cAMP-dependent protein kinase during chemotactic cell migration. PNAS 2005, 102:14320-14325.
57. Ge L., Shenoy S.K., Lefkowitz R.J., DeFea K. Constitutive protease-activated receptor-2-mediated migration of MDA MB-231 breast cancer cells requires both beta-arrestin-1 and -2. J Biol Chem 2004, 279:55419-55424.
58. Ge L., Hollenberg M., DeFea K. A beta-arrestin-dependent scaffold is associated with prolonged MAPK activation in pseudopodia during protease-activated receptor-2-induced chemotaxis. J Biol Chem 2003, 278:34418-34426.
59. Wang P., DeFea K. Protease-activated receptor-2 simultaneously directs beta-arrestin-1-dependent inhibition and Galphaq-dependent activation of phosphatidylinositol 3-kinase. Biochemistry 2006, 45:9374-9385.
60. Beckner M.E., Fellows-Mayle W., Zhnag Z., Agostino N.R., Kant J.A., Day B.W., Pollack I.F. Identification of ATP citrate lyase as a positive regulator of glycolytic function in glioblastomas. Int J Cancer 2010, 126:2282-2295.